Aleks Engel is a partner with Novo Holdings where he has worked for 10 years. He is the Director of the REPAIR Impact Fund, a founding board member of the AMR Action Fund, and a board member of Paratek Pharmaceuticals, a commercial anti-infectives company. Aleks is based in Boston
Panel of investors in AMR will discuss deal dynamics and areas of particular interest.